arrow

From NeuroLex

Jump to: navigation, search



Resource:Adenoma Polyp Tissue Bank

Name: Resource:Adenoma Polyp Tissue Bank
Description: The Adenoma Polyp Tissue Bank (APTB) receives whole blood from patients enrolled in the Prevention of Sporadic Colorectal Adenomas with Celecoxib clinical trial. We have reached our accrual on blood submissions, so we will no longer be receiving blood specimens

The objectives of this trial are as follows:
A. To determine the efficacy and safety of celecoxib versus placebo in preventing the occurrence of newly detected colorectal adenomas in subjects at increased risk for colorectal carcinoma. In addition to incidence, other established risk factors will be evaluated for their association with occurrence of new colorectal adenomas, including cancer family history and adenoma size, histopathologic grade, multiplicity and location. Primary assessment of treatment efficacy will be the reduction in the number of subjects with adenomas at colonoscopy after Year 1 and Year 3 of study drug use. Secondary assessments of treatment efficacy will be 1) the number of adenomas 2) the histopathologic grade of adenomas and 3) the size of adenomas, also measured after one year and three years of study drug use. These factors will be incorporated into a risk model for predicting adenoma occurrence and response to celecoxib.

B. To determine the efficacy of celecoxib versus placebo in modulating one or more of a panel of biomarkers for colorectal cancer at the cellular and molecular level sampled in a subset of subjects at selective sites at baseline and after Year 1 and Year 3 of study drug use. These biomarkers will include measurements of aberrant crypt foci (ACF), proliferation (index and crypt distribution), apoptosis (index and crypt distribution), COX expression and activity. If modulation of one or more mucosal biomarkers occur, we will explore whether it correlates with the development of incident colorectal neoplasia (adenomas/carcinomas), thereby attempting to validate the surrogacy of that biomarker.

C. To develop a specimen bank. Serum and white blood cells are isolated from whole blood and adenoma tissue blocks and slides are banked. Banked specimens will become available for use in correlative science studies at a later point. This project began in 1999 and will be extended through 2006. The lead principal investigator is Monica M. Bertagnolli, MD, Brigham and Women's Hospital, Boston, MA, and the APTB Director is Scott Jewell, Ph.D., Department of Pathology, The Ohio State University. The APTB is supported by the NIH, NCI Division of Cancer Prevention, in connection with the Strang Cancer Prevention Center, Cornell University, New York.
Other Name(s): APTB Specimen Bank
Abbreviation: APTB
Parent Organization: Resource:Human Tissue Resource Network
Supporting Agency: NCI
Resource Type(s): Biomaterial supply resource
Resource: Resource
URL: http://www.pathology.med.ohio-state.edu/HTRN/apc/default.asp
*Id: nlx_144435
Related condition/disease: Increased risk for colorectal carcinoma
Related application: Research
Processing: Block, Slide
Related to: Resource:One Mind Biospecimen Bank Listing, US Biobank
Availability: Public?: Banked specimens will become available for use in correlative science studies at a later point.
Address: APTB, Innovation Centre, 2001 Polaris Parkway, Columbus, OH - 43240 Phone: 614-293-6906 Fax: 614-293-7013
Keywords: Blood, Serum, White blood cell, Adenoma tissue, Tissue, Whole blood, Block, Slide, Colorectal adenoma, Celecoxib, Adenoma, Cancer, Colorectal cancer, Clinical trial, Polyp, Risk factor
Organism: Human
Link to OWL / RDF: Download this content as OWL/RDF

Curation status: Uncurated

This resource will be curated within 7 days.

For Resource Owners:
After the resource is curated, you may create a sitemap, which will help keep your registry description up-to-date and inform search engines about your resource.

Note: For a new resource, the website's URL must first be verified by a NIF curator before you may proceed.

Learn more about what NIF can do for your resource.
Proudly proclaim your inclusion in NIF by displaying the "Registered with NIF" button on your site. Please login to create the sitemap. (top right)

Notes

This page uses this default form:Resource

Contributors

Aarnaud, Ccdbuser



bookmark

*Note: Neurolex imports many terms and their ids from existing community ontologies, e.g., the Gene Ontology. Neurolex, however, is a dynamic site and any content beyond the identifier should not be presumed to reflect the content or views of the source ontology. Users should consult with the authoritative source for each ontology for current information.

Facts about Resource:Adenoma Polyp Tissue BankRDF feed
AbbrevAPTB  +
AddressAPTB  +, Innovation Centre  +, 2001 Polaris Parkway  +, Columbus  +, and OH - 43240 Phone: 614-293-6906 Fax: 614-293-7013  +
AvailabilityPublic?: Banked specimens will become available for use in correlative science studies at a later point.  +
CommentSample type: Blood, Serum, White blood cell, Adenoma tissue, Whole blood, Tissue
CurationStatuscurated  +
DefiningCitationhttp://www.pathology.med.ohio-state.edu/HTRN/apc/default.asp  +
DefinitionThe Adenoma Polyp Tissue Bank (APTB) recei The Adenoma Polyp Tissue Bank (APTB) receives whole blood from patients enrolled in the Prevention of Sporadic Colorectal Adenomas with Celecoxib clinical trial. We have reached our accrual on blood submissions, so we will no longer be receiving blood specimens

The objectives of this trial are as follows:
A. To determine the efficacy and safety of celecoxib versus placebo in preventing the occurrence of newly detected colorectal adenomas in subjects at increased risk for colorectal carcinoma. In addition to incidence, other established risk factors will be evaluated for their association with occurrence of new colorectal adenomas, including cancer family history and adenoma size, histopathologic grade, multiplicity and location. Primary assessment of treatment efficacy will be the reduction in the number of subjects with adenomas at colonoscopy after Year 1 and Year 3 of study drug use. Secondary assessments of treatment efficacy will be 1) the number of adenomas 2) the histopathologic grade of adenomas and 3) the size of adenomas, also measured after one year and three years of study drug use. These factors will be incorporated into a risk model for predicting adenoma occurrence and response to celecoxib. B. To determine the efficacy of celecoxib versus placebo in modulating one or more of a panel of biomarkers for colorectal cancer at the cellular and molecular level sampled in a subset of subjects at selective sites at baseline and after Year 1 and Year 3 of study drug use. These biomarkers will include measurements of aberrant crypt foci (ACF), proliferation (index and crypt distribution), apoptosis (index and crypt distribution), COX expression and activity. If modulation of one or more mucosal biomarkers occur, we will explore whether it correlates with the development of incident colorectal neoplasia (adenomas/carcinomas), thereby attempting to validate the surrogacy of that biomarker.

C. To develop a specimen bank. Serum and white blood cells are isolated from whole blood and adenoma tissue blocks and slides are banked. Banked specimens will become available for use in correlative science studies at a later point. This project began in 1999 and will be extended through 2006. The lead principal investigator is Monica M. Bertagnolli, MD, Brigham and Women's Hospital, Boston, MA, and the APTB Director is Scott Jewell, Ph.D., Department of Pathology, The Ohio State University. The APTB is supported by the NIH, NCI Division of Cancer Prevention, in connection with the Strang Cancer Prevention Center, Cornell University, New York.
tion Center, Cornell University, New York.
ExampleImageAPTB.PNG  +
Has default formThis property is a special property in this wiki.Resource  +
Has roleBiomaterial supply resource  +
Idnlx_144435  +
Is part ofResource:Human Tissue Resource Network  +
KeywordsBlood  +, Serum  +, White blood cell  +, Adenoma tissue  +, Tissue  +, Whole blood  +, Block  +, Slide  +, Colorectal adenoma  +, Celecoxib  +, Adenoma  +, Cancer  +, Colorectal cancer  +, Clinical trial  +, Polyp  +, and Risk factor  +
LabelResource:Adenoma Polyp Tissue Bank  +
ListedbyResource:One Mind Biospecimen Bank Listing  +, and US Biobank  +
ModifiedDate30 September 2014  +
Page has default formThis property is a special property in this wiki.Resource  +
ProcessingBlock  +, and Slide  +
RelatedToResource:One Mind Biospecimen Bank Listing  +, and US Biobank  +
Related applicationResearch  +
Related diseaseIncreased risk for colorectal carcinoma  +
SpeciesHuman  +
SuperCategoryResource  +
Supporting AgencyNational Cancer Institute  +
SynonymAPTB Specimen Bank  +